These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3816545)

  • 21. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
    Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compatibility of furosemide with aminoglycoside admixtures.
    Thompson DF; Allen LV; Desai SR; Rao PS
    Am J Hosp Pharm; 1985 Jan; 42(1):116-9. PubMed ID: 3970026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapy.
    Mitrzyk B; Jarco PE; Rybak MJ
    Am J Health Syst Pharm; 1996 Dec; 53(23):2855-9. PubMed ID: 8957347
    [No Abstract]   [Full Text] [Related]  

  • 24. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
    James MJ; Riley CM
    Am J Hosp Pharm; 1985 Sep; 42(9):1984-6. PubMed ID: 4050817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
    Woo FL; Johnson AP; Insler MS; George WJ; LaCorte WS
    Arch Ophthalmol; 1985 Feb; 103(2):216-8. PubMed ID: 3977692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):66-75. PubMed ID: 28346199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of amikacin, gentamicin, or tobramycin in 10% dextrose injection.
    Wolff DJ; Kline SS; Mauro LS
    Am J Hosp Pharm; 1994 Feb; 51(4):518-9. PubMed ID: 8017421
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection.
    Steigbigel RT; Greenman RL; Remington JS
    J Infect Dis; 1975 Mar; 131(3):245-51. PubMed ID: 1127254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
    Tack KJ; Sabath LD
    Chemotherapy; 1985; 31(3):204-10. PubMed ID: 3888545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
    Hall PD; Yui D; Lyons S; Bosso JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):185-9. PubMed ID: 9117808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M; Poisson M
    J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic.
    Uematsu T; Mizuno A; Suzuki Y; Sato R; Yamazaki T; Nakashima M
    Ther Drug Monit; 1988; 10(4):459-62. PubMed ID: 3201531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
    Allen LV; Stiles ML; Prince SJ; Sylvestri MF
    Am J Health Syst Pharm; 1995 Nov; 52(21):2427-33. PubMed ID: 8564608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions - part II.
    Nunning BC; Granatek AP
    Curr Ther Res Clin Exp; 1976 Oct; 20(4):359-68. PubMed ID: 12917
    [No Abstract]   [Full Text] [Related]  

  • 38. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
    Muscato JJ; Wilbur DW; Stout JJ; Fahrlender RA
    J Antimicrob Chemother; 1991 May; 27 Suppl C():1-7. PubMed ID: 1906860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of parenteral solutions of tobramycin sulfate.
    Bergstrom RF; Fites AL; Lamb JW
    Am J Hosp Pharm; 1975 Sep; 32(9):887-8. PubMed ID: 242216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of ranitidine in intravenous admixtures stored frozen, refrigerated, and at room temperature.
    Stewart JT; Warren FW; Johnson SM; Galante LJ
    Am J Hosp Pharm; 1990 Sep; 47(9):2043-6. PubMed ID: 2220860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.